Literature DB >> 6468876

Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens.

M J Blaser, R A Miller, J Lacher, J W Singleton.   

Abstract

A variety of bacterial pathogens including Campylobacter, Yersinia, Listeria, Brucella, and Mycobacteria have been suggested as potential etiologic agents for Crohn's disease. To assess the role of these organisms we studied responses to eight antigens in sera from patients with active Crohn's disease and healthy age- and sex-matched controls. In complement-fixation assays, the sera from the Crohn's disease patients had enhanced reactivity compared with the control sera to all seven orally ingested pathogens studied; however, only the difference in distribution of titers to Yersinia pseudotuberculosis was statistically significant (p less than 0.0025). There was no difference between the two groups in reactivity to arabinomannan, a common mycobacterial antigen. Seroreactivity to enteric pathogens not resident in the bowel flora probably represents a nonspecific sensitization to cross-reacting antigens. Lack of response to the mycobacterial antigen suggests that widespread mycobacterial disease with high bacillary load is not present in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6468876

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  30 in total

1.  Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease.

Authors:  C L Sutton; H Yang; Z Li; J I Rotter; S R Targan; J Braun
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

2.  Measles virus serology in Crohn's disease.

Authors:  N C Fisher; L Yee; P Nightingale; R McEwan; J A Gibson
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

3.  The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease.

Authors:  Marleen H M C van Nuenen; Koen Venema; Janneke C J van der Woude; Ernst J Kuipers
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

Review 4.  Immunopathogenesis of inflammatory bowel disease.

Authors:  David Q Shih; Stephan R Targan
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 5.  Potential role of superantigen induced activation of cell mediated immune mechanisms in the pathogenesis of Crohn's disease.

Authors:  J P Ibbotson; J R Lowes
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

6.  Effect of intestinal resection on serum antibodies to the mycobacterial 45/48 kilodalton doublet antigen in Crohn's disease.

Authors:  G Kreuzpaintner; P K Das; A Stronkhorst; A W Slob; G Strohmeyer
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

7.  A limiting-dilution analysis of activated circulating B cells in Crohn's disease.

Authors:  M Boirivant; F Quintieri; O Pugliese; G Famularo; S Fais; F Pallone
Journal:  J Clin Immunol       Date:  1990-03       Impact factor: 8.317

8.  Detection of antibody to group B adult diarrhea rotaviruses in humans.

Authors:  S Nakata; M K Estes; D Y Graham; S S Wang; G W Gary; J L Melnick
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

9.  Mycobacterial aetiology of Crohn's disease: serologic study using common mycobacterial antigens and a species-specific glycolipid antigen from Mycobacterium paratuberculosis.

Authors:  S N Cho; P J Brennan; H H Yoshimura; B I Korelitz; D Y Graham
Journal:  Gut       Date:  1986-11       Impact factor: 23.059

10.  Location of acyl groups of trehalose-containing lipooligosaccharides of mycobacteria.

Authors:  R T Camphausen; M McNeil; I Jardine; P J Brennan
Journal:  J Bacteriol       Date:  1987-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.